Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-10-24 CELGENE CORP /DE/ 10% owner Purchase +800,150 $14.00 $11.2M 4,834,980
2016-10-24 CELGENE CORP /DE/ 10% owner Conversion · Series B Preferred Shares −4,034,830 0
2016-10-24 George Simeon Director Conversion +2,942,560 2,942,560
2016-10-24 George Simeon Director Conversion +211,567 3,154,127
2016-10-24 George Simeon Director Purchase +66,500 $14.00 $931K 3,220,627
2016-10-24 George Simeon Director Conversion · Series A-3 Preferred Shares −2,942,560 0
2016-10-24 George Simeon Director Conversion · Series B Preferred Shares −211,567 0
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Conversion +2,942,560 2,942,560
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Conversion +211,567 3,154,127
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Purchase +66,500 $14.00 $931K 3,220,627
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Conversion · Series A-3 Preferred Shares −2,942,560 0
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Conversion · Series B Preferred Shares −211,567 0
2016-10-24 COLES N ANTHONY Director Grant or award +35,000 $14.00 $490K 70,000
2016-10-24 COLES N ANTHONY Director Grant or award +35,000 $14.00 $490K 70,000
2016-10-24 Versant Venture Capital IV, L.P. 10% owner Grant or award +95,596 $14.00 $1.3M 4,104,045
2016-10-24 Versant Venture Capital IV, L.P. 10% owner Grant or award +602 $14.00 $8K 24,334
2016-10-24 Versant Venture Capital IV, L.P. 10% owner Grant or award +60,219 $14.00 $843K 2,443,803
2016-10-24 Versant Venture Capital IV, L.P. 10% owner Grant or award +4,583 $14.00 $64K 185,987
2016-10-24 Hadley Harbor Master Investors (Cayman) L.P. 10% owner Conversion +744,380 744,380
2016-10-24 Hadley Harbor Master Investors (Cayman) L.P. 10% owner Conversion · Series B Convertible Preferred Shares −744,380 0

Page 73 of 74 · 1,471 trades